Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression - Wikidata - awgldk - TriplyDB

Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression

Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression

http://www.wikidata.org/entity/Q34674065

about

Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic Role of BmDredd during Apoptosis of Silk Gland in Silkworm, Bombyx mori NIH workshop on clinical translation of molecular imaging probes and technology--meeting report.Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid.AEG-1 promoter-mediated imaging of prostate cancer.Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability.Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).Molecular-genetic imaging of cancer.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Gene Therapies for Cancer: Strategies, Challenges and Successes.Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker.Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs Tumor-specific expression and detection of a CEST reporter gene.A novel imaging method for correlating 2D light microscopic data and 3D volume data based on block-face imaging Regulatory Forum Opinion Piece*: Imaging Applications in Toxicologic Pathology-Recommendations for Use in Regulated Nonclinical Toxicity Studies.Targeted polymeric nanoparticles for cancer gene therapy.Functional multiplex reporter assay using tagged Gaussia luciferase.MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery.Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules A nanoparticle formulation that selectively transfects metastatic tumors in mice Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts : biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(Bioluminescence imaging: progress and applications Cancer imaging: Gene transcription-based imaging and therapeutic systems.Overview of Transgenic Glioblastoma and Oligoastrocytoma CNS Models and Their Utility in Drug Discovery A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.Detecting Tumor Metastases: The Road to Therapy Starts Here.Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimetic.Imaging mouse cancer models in vivo using reporter transgenes.Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).Cancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.Cancer Terminator Viruses (CTV): A Better Solution for Viral-Based Therapy of Cancer.Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy.Optimized application of the secreted Nano-luciferase reporter system using an affinity purification strategy.

P2860

Q26741197-A7AC8FDF-20EF-4C7F-8CB8-4DC3E54A3ADC Q27694606-F658B170-D7D1-40EE-877C-BD3414389C49 Q28469352-342D2DBA-92C8-4CD1-9B0A-A0586EBC7E7E Q30430958-60FFF420-E795-4CC6-AE1B-38EF97B8E887 Q34438516-1FCEB128-F68B-4911-B0BD-2A4CC3C4E9BB Q34522714-A5E67CE9-DADB-4DD6-A221-B22C2D8B0367 Q34593139-4670CE2C-3F8C-4B32-B283-3918C090CEFF Q35095082-EA5697E5-2AB1-4EDC-90BC-56A7FAD03BBD Q35116121-CB5B624C-54B9-4798-933C-2026AE62D341 Q35142325-D33BF908-5021-4FD7-B677-444AE763106D Q35186312-29236D78-2711-4B8B-8986-C5DAAE4251B4 Q35190027-442606E3-DBFE-4A1C-8974-DE24426CA82D Q35256725-D0B4A678-79F7-43EA-BC48-89240F4A4D7F Q35769802-51B90A11-8570-4638-96D5-3373B65CC4BA Q36182137-F2D6F2DA-7FA5-4D4F-A9AF-124B50ED6A93 Q36407749-BC7AF36F-46D1-4B9B-92E7-02CC30CD4CAD Q36412738-FF6B8315-D0AC-4D94-9386-7119F571CC1C Q36416427-A81D8648-2FFF-414F-8B65-730876CB8100 Q36522297-1450AA9E-A0F4-4BD8-B3FF-A9202F437FB7 Q36545635-0B003959-7E30-473C-A963-7411CC31EC71 Q36793350-D6B4CF48-4AA9-4F29-8D3F-94D817073E39 Q37149641-E8B4F23E-23DB-47F8-B0D4-9137BF2A207F Q37157373-239EBFD0-9238-4F24-897F-AC06825E0C9E Q37561277-E6BB0D97-960D-4E78-A34A-29C441BFCD48 Q37905334-9BA57B37-DAD8-4D34-8673-7F366E56DFBE Q37986315-54CF03D9-746E-4327-91F1-462E05200D42 Q38781953-A4038AB5-0D5B-40AF-A536-36011C401102 Q38817672-4A56BD6F-72EB-4A8D-8F93-40460792F72B Q38950545-EE438E64-2C6E-4220-B2D1-64DCF0F00FE3 Q40437589-4967CE4A-D52A-4592-A9FF-1A559EAFA19A Q43983077-C46C085D-3E94-4B33-B947-43E867398006 Q45871873-290FF5C6-0245-46C5-AABD-C0BFA0CABA79 Q45885614-FC3F5926-6F5E-494D-9AB5-2041BAF383E3 Q47560447-B26001BC-057F-49DE-887E-7DE0819C372E Q48556437-C68F0CF8-A85E-4E7B-903B-373F2D386123 Q54965253-DE325A0E-929C-4CF1-A666-EA0324459D74

P2860

Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression

http://www.wikidata.org/entity/Q34674065

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Tumor-specific imaging through ...... romoter-driven gene expression

@ast

Tumor-specific imaging through ...... romoter-driven gene expression

@en

Tumor-specific imaging through ...... romoter-driven gene expression

@nl

type

label

Tumor-specific imaging through ...... romoter-driven gene expression

@ast

Tumor-specific imaging through ...... romoter-driven gene expression

@en

Tumor-specific imaging through ...... romoter-driven gene expression

@nl

prefLabel

Tumor-specific imaging through ...... romoter-driven gene expression

@ast

Tumor-specific imaging through ...... romoter-driven gene expression

@en

Tumor-specific imaging through ...... romoter-driven gene expression

@nl

P1433

Q34674065-216CC2F8-455E-42FC-9360-D61D9B230F6A

P1476

Q34674065-6DEE9144-8818-411A-AFC1-82E82C6EA9D8

P2093

Q34674065-25DC6C65-2EF0-43D2-A62F-C7A2E0817CC3

Q34674065-362E8451-5787-47FF-91E9-C616207E70A2

Q34674065-425059B9-1882-484A-BD3A-6C6C5A32EBD4

Q34674065-4C5834C0-390D-4527-89AC-AF72B3C0D313

Q34674065-DA6624C0-65B9-4985-9C23-8994E0E225C6

P2860

Q34674065-0715B13E-0777-457E-99E3-00411F6D373C

Q34674065-0D8FBEEB-015E-45D0-89A1-E4C82125621E

Q34674065-2386FB46-19BB-49CB-9C9F-21C89B49B3A4

Q34674065-23BF521B-4B8A-4438-8DE1-A39B29981CCD

Q34674065-2D4D7A9F-33B0-4DE7-9E31-893FFA279F7D

Q34674065-30262357-B395-4088-9F4C-1B35BF337D59

Q34674065-446A726A-354A-4637-B4BF-BFF9DD07B51D

Q34674065-4ADADAA4-4BD5-4061-BBCF-FFCCE60E7422

Q34674065-5033F67C-8293-4719-B985-20E4666AF7D6

Q34674065-50F46550-8799-4128-91C6-52DE292DA8A3

P2888

Q34674065-292BC32A-31FC-4E9D-8F91-12BFB052142C

P304

Q34674065-78B28D6D-C452-4EAD-8B4B-1865D429099D

P31

Q34674065-EFDAB6D0-6ADC-48E8-8407-40C27EBA35B3

P356

Q34674065-04988B78-6746-4E5C-893C-6B3E3D527E87

P407

Q34674065-4D0C300C-2CE1-4E90-91E2-F928111AE2E5

P433

Q34674065-AEAB894F-3399-4441-8A73-8D828275AF21

P478

Q34674065-D5F91113-14AF-4D76-B0C2-16AD2A89E3AC

P577

Q34674065-EA0F984B-A804-4780-A7CF-E36FB74A1AC7

P5875

Q34674065-4A037E94-5A9D-425A-904D-2F01459A5300

P698

Q34674065-145F008A-51D5-437F-802F-F08555B7D6BF

P932

Q34674065-612120D1-1E52-453D-8A19-D57B69EADC3C

P356

P1433

Nature Medicine

P1476

Tumor-specific imaging through ...... romoter-driven gene expression

@en

P2093

Hyo-eun C Bhang

http://www.w3.org/2001/XMLSchema#string

John Laterra

http://www.w3.org/2001/XMLSchema#string

Kathleen L Gabrielson

http://www.w3.org/2001/XMLSchema#string

Martin G Pomper

http://www.w3.org/2001/XMLSchema#string

Paul B Fisher

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma

Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery.

Potential molecular mechanism for rodent tumorigenesis: mutational generation of Progression Elevated Gene-3 (PEG-3)

GAL4-VP16 is an unusually potent transcriptional activator

Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.

A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis.

Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.

Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.

Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.

Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct.

P2888

P304

123-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2269

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49676853

http://www.w3.org/2001/XMLSchema#string

P698

21151140

http://www.w3.org/2001/XMLSchema#string

P932

3057477

http://www.w3.org/2001/XMLSchema#string